262 related articles for article (PubMed ID: 18645026)
1. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation.
Zhou J; Lu GD; Ong CS; Ong CN; Shen HM
Mol Cancer Ther; 2008 Jul; 7(7):2170-80. PubMed ID: 18645026
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide Enhances TRAIL-Induced Apoptosis via
Deng Y; Bi R; Guo H; Yang J; Du Y; Wang C; Wei W
Int J Biol Sci; 2019; 15(3):688-700. PubMed ID: 30745855
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Wei RJ; Zhang XS; He DL
Asian J Androl; 2018; 20(2):200-204. PubMed ID: 28869219
[TBL] [Abstract][Full Text] [Related]
4. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway.
Gupta SC; Francis SK; Nair MS; Mo YY; Aggarwal BB
J Biol Chem; 2013 Nov; 288(45):32343-32356. PubMed ID: 24078627
[TBL] [Abstract][Full Text] [Related]
5. Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression.
Ding J; Polier G; Köhler R; Giaisi M; Krammer PH; Li-Weber M
J Biol Chem; 2012 Jan; 287(1):641-649. PubMed ID: 22086925
[TBL] [Abstract][Full Text] [Related]
6. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation.
Moon DO; Kim MO; Choi YH; Kim GY
Mol Cancer Ther; 2010 Jun; 9(6):1583-95. PubMed ID: 20515942
[TBL] [Abstract][Full Text] [Related]
7. Calyculin A causes sensitization to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by ROS-mediated down-regulation of cellular FLICE-inhibiting protein (c-FLIP) and by enhancing death receptor 4 mRNA stabilization.
Woo SM; Min KJ; Kwon TK
Apoptosis; 2012 Nov; 17(11):1223-34. PubMed ID: 22911475
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide sensitizes human renal carcinoma cells to TRAIL‑induced apoptosis through upregulation of death receptor 4.
Bi R; Deng Y; Tang C; Xuan L; Xu B; Du Y; Wang C; Wei W
Oncol Rep; 2020 Nov; 44(5):1939-1948. PubMed ID: 33000263
[TBL] [Abstract][Full Text] [Related]
9. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK.
Prasad S; Yadav VR; Kannappan R; Aggarwal BB
J Biol Chem; 2011 Feb; 286(7):5546-57. PubMed ID: 21156789
[TBL] [Abstract][Full Text] [Related]
10. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT
Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278
[TBL] [Abstract][Full Text] [Related]
11. Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression.
Jang JY; Jeon YK; Choi Y; Kim CW
Mol Cancer; 2010 Sep; 9():262. PubMed ID: 20875141
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
[TBL] [Abstract][Full Text] [Related]
13. Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z
Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP.
Seo BR; Min KJ; Woo SM; Choe M; Choi KS; Lee YK; Yoon G; Kwon TK
Antioxid Redox Signal; 2017 Aug; 27(4):215-233. PubMed ID: 27927016
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
Yoo J; Park SS; Lee YJ
J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
[TBL] [Abstract][Full Text] [Related]
16. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation.
Chen L; Meng Y; Guo X; Sheng X; Tai G; Zhang F; Cheng H; Zhou Y
Apoptosis; 2016 Nov; 21(11):1291-1301. PubMed ID: 27629794
[TBL] [Abstract][Full Text] [Related]
18. Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation.
Carlisi D; D'Anneo A; Angileri L; Lauricella M; Emanuele S; Santulli A; Vento R; Tesoriere G
J Cell Physiol; 2011 Jun; 226(6):1632-41. PubMed ID: 21413021
[TBL] [Abstract][Full Text] [Related]
19. Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins.
Prasad S; Ravindran J; Sung B; Pandey MK; Aggarwal BB
Mol Cancer Ther; 2010 Apr; 9(4):856-68. PubMed ID: 20371723
[TBL] [Abstract][Full Text] [Related]
20. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells.
Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY
Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
